Home > Insider Trading > Filing (0000059478-17-000239)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463321	Susan Mahony	Lilly Corporate Center Indianapolis IN 46285	Svp & Pres., Lilly Oncology	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-04	36,585	$86.18	54,885	No	4	S	Direct
Common Stock	Disposition	2017-11-03	15,861	$0.00	39,024	No	5	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	5	G	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,726	Indirect	401(k)
Common Stock	1,715	Indirect	401(k) - by husband
Common Stock	13,509	Indirect	by husband

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2017.
This transaction was executed in multiple trades at prices ranging from $85.39 to $86.71. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Reporting person disclaims beneficial ownership of these shares.